Evidence map›Paper›PMID 34746851›Full record

ArticleJACC. CardioOncology2021

Genomic Screening for Pathogenic Transthyretin Variants Finds Evidence of Underdiagnosed Amyloid Cardiomyopathy From Health Records.

Brendan J Carry, Katelyn Young, Samuel Fielden, Melissa A Kelly, Amy C Sturm, J David Avila, Christa L Martin, H Lester Kirchner, Brandon K Fornwalt, Christopher M Haggerty and 1 more

Open access · goldAbstract read
In one paragraph

Article in JACC. CardioOncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pre-symptomatic scintigraphic and genetic cascade screening in cardiac transthyretin amyloidosis.European journal of nuclear medicine and molecular imaging · 2025
    Trial
  3. Review
  4. Review
  5. Developing a phenotype risk score formedRxiv : the preprint server for health sciences · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Evolving knowledge of red flag clinical features associated with TTR p.(Val142Ile) in a diverse electronic health-record-linked biobank.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Brendan J CarryHeart Institute, Geisinger Medical Center, Danville, Pennsylvania, USA.
Katelyn YoungDepartment of Internal Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA.
Samuel FieldenDepartment of Translational Data Science and Informatics, Geisinger Medical Center, Danville, Pennsylvania, USA.
Melissa A KellyGenomic Medicine Institute, Geisinger Medical Center, Danville, Pennsylvania, USA.
Amy C SturmHeart Institute, Geisinger Medical Center, Danville, Pennsylvania, USA.
J David AvilaDepartment of Neurology, Geisinger Medical Center, Danville, Pennsylvania, USA.
Christa L MartinGenomic Medicine Institute, Geisinger Medical Center, Danville, Pennsylvania, USA.
H Lester KirchnerDepartment of Population Health Sciences, Geisinger Medical Center, Danville, Pennsylvania, USA.
Brandon K FornwaltHeart Institute, Geisinger Medical Center, Danville, Pennsylvania, USA.
Christopher M HaggertyHeart Institute, Geisinger Medical Center, Danville, Pennsylvania, USA.
Regeneron Genetics Center, Tarrytown, New York, USA
Geisinger Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNew treatments for transthyretin amyloidosis improve survival, but diagnosis remains challenging. Pathogenic or likely pathogenic (P/LP) variants in the transthyretin (

objectivesThis study characterized the prevalence of P/LP variants in

methodsWe compared frequencies of common disease features and cardiac imaging findings between individuals with and without P/LP

resultsWe identified 157 of 134,753 (0.12%) individuals with P/LP

conclusionsIndividuals with P/LP

Indexed as

amyloidosisATTR, transthyretin amyloidosiscardiomyopathyCI, confidence intervalEHR, electronic health recordelectronic health recordsgenomicshATTR, hereditary transthyretin amyloidosisHCC, hierarchical condition categoriesLP, likely pathogenicLV, left ventricle/ventricularOR, odds ratioP, pathogenicTTR, transthyretin

Identifiers

PMID34746851
PMCPMC8543083
OpenAlexW3207014950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.